Consun Pharmaceutical Group Ltd Financials

Market Capitalization HK$12.48 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	11.87
Forward PE	9.48
Price to Sales TTM	HK$4.00
Price to Book MRQ	HK$2.73
Enterprise to Revenue	2.98
Enterprise to EBITDA	8.66

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	30.88%
Operating Margin	32.82%
Return on Assets TTM	11.58%
Return on Equity TTM	23.60%

Income Statement

Revenue TTM	HK$3,633,143,324
Revenue per Share TTM	HK$3.86
Quarterly Revenue Growth	23.70%
Gross Profit TTM	HK$2,783,574,948
EBITDA	HK$1,223,797,372
Net Income to Common TTM	HK$1,121,978,924
Diluted EPS TTM	HK$1.31
Quarterly Earnings Growth YoY	24.60%

Balance Sheet

Total Cash MRQ	HK$4,489,416,745
Total Cash per Share MRQ	HK$4.75
Total Debt MRQ	HK$
Total Debt to Equity MRQ	5.45
Current Ratio MRQ	3.54
Book Value per Share MRQ	HK$5.69

Cash Flow

Operating Cash Flow TTM	HK$1,367,004,802
Levered Free Cash Flow TTM	HK$879,334,995

1681 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	850,331,745
Float Shares	461,815,171
Avg 10 Volume	1,239,623
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	45.24%
% Held by Institutions	17.78%

Stock Price Summary

Beta	0.53
Fifty Two Week Low	HK$7.35
Fifty Two Week High	HK$17.68
Fifty Two Week Change	49.52%
Day 50 MA	HK$15.09
Day 200 MA	HK$12.93

Dividends and Splits

Forward Annual Dividend Rate	HK$0.66
Forward Annual Dividend Yield	4.24%
Trailing Annual Dividend Rate	HK$0.63
Trailing Annual Dividend Yield	4.05%
Payout Ratio	46.36%
Dividend Date
Ex Dividend Date	2025-09-04
Last Split Factor
Last Split Date